Quantinno Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Quantinno Capital Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,617	Closed	-$494K	–	586
2019 Q4	$494K	Sell	5,617 -3,734	-40%	-$315K	0.31%	106
2019 Q3	$706K	Buy	9,351 +1,101	+13%	+$89.4K	0.48%	18
2019 Q2	$705K	Buy	+8,250	New	+$816K	0.41%	34
2019 Q1	–	Sell	-3,450	Closed	-$292K	–	486
2018 Q4	$292K	Buy	+3,450	New	+$333K	0.24%	210

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Quantinno Capital Management's TARO Position: Q1 2020 in Review

Quantinno Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2020, closing a stake of 5,617 shares — an estimated $494K sold.

Quantinno Capital Management first reported a position in TARO in Q4 2018 and held it in 4 quarters. The position peaked at $706K in Q3 2019. 90 funds tracked by Wall St. Rank hold TARO as of Q1 2020.

Quantinno Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2020 after selling out during the quarter.
Quantinno Capital Management sold 5,617 Taro Pharmaceutical Industries Ltd. shares in Q1 2020, an estimated $494K.
Quantinno Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2018 and held it in 4 quarters.
Quantinno Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $706K in Q3 2019.
90 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2020.

Based on Quantinno Capital Management's 13F filing for Q1 2020, filed 15 May 2020.